|
|
- 2019
Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United StatesDOI: 10.1002/cam4.1869 Keywords: bisphosphonates, electronic health records, medical record linkage, multiple myeloma, zoledronic acid Abstract: Prior to 2018, intravenous bisphosphonates (IV BPs) were the only therapies recommended to prevent skeletal‐related events for patients diagnosed with multiple myeloma (MM). We examined patterns of IV BP initiation and interruption among patients with newly diagnosed MM (NDMM) in the United States
|
